Inotiv, Inc. continues to expand genetic toxicology

WEST LAFAYETTE, Ind., July 26, 2022 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in non-clinical and analytical drug discovery and development services and research models and related products and services, today announced that the company has significantly expanded its capacity to conduct good …

Inotiv, Inc. continues to expand genetic toxicology Read More »